Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
34
Number of overlapping holdings
15.2%
% of IBB's 261 holdings also in GNOM
87.2%
% of GNOM's 40 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus GNOM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in GNOM |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 3.6% | 4.7% | 3.6% |
|
GILEAD SCIENCES INC | 8.2% | 3.3% | 3.3% |
|
VERTEX PHARMACEUTICALS INC | 8.6% | 2.7% | 2.7% |
|
NATERA INC | 2.0% | 6.3% | 2.0% |
 |
BIONTECH SE SPONSORED ADR | 1.7% | 4.4% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to GNOM
|
AMGEN INC | 8.4% |
|
REGENERON PHARMACEUTICALS | 7.3% |
|
VERTEX PHARMACEUTICALS INC | 5.9% |
|
GILEAD SCIENCES INC | 4.9% |
|
IQVIA HOLDINGS INC | 3.4% |
 |
ARGENX SE ADR | 2.7% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.6% |
|
WATERS CORP | 2.3% |
|
BIOGEN IDEC INC | 2.2% |
|
BEIGENE LTD. SPONSORED ADR | 1.6% |
IBB Underweight Relative to GNOM
|
VERACYTE INC | -4.5% |
|
AGILENT TECHNOLOGIES INC | -4.5% |
|
NATERA INC | -4.3% |
 |
GENSCRIPT BIOTECH CORPORATION | -4.2% |
|
CRISPR THERAPEUTICS AG | -3.8% |
|
BIOMARIN PHARMACEUTICAL INC | -3.8% |
|
BEAM THERAPEUTICS, INC. | -3.7% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -3.6% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.4% |
|
BIO-TECHNE CORPORATION | -3.4% |